NLRP3 and atherosclerosis: Furthermore, our results may have significant therapeutic ramifications for the treatment of CAPS, sepsis, atherosclerosis, Parkinson’s disease, and many other diseases in which excessive NLRP3 inflammasome activation contributes to pathology.